Pradžia › Plaučių ligos › Alabama
Plaučių ligos klinikiniai tyrimai Alabama
13 tyrimai dėl Plaučių ligos ieško dalyvių vietose Alabama.
Miestai Alabama
Oficialus tyrimo tekstas (anglų kalba)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Birmingham
- Research Site, Mobile
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT05624450A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- University of Alabama at Birmingham, Huntsville Regional Medical Campus (HRMC), Huntsville
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06679140Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- Clearview Cancer Institute (Crestwood), Huntsville
- Clearview Cancer Institute, Huntsville
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07489066A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- University of Alabama at Birmingham, Birmingham
Renkami dalyviai2 fazė
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07759245American Lung Association (ALA) Lung Health Cohort
- University Of Alabama, Birmingham
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 25 iki 35 · Visoms lytims · Atnaujinta 2026-09-23 · NCT04543461A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Velocity Clinical Research, Mobile, Mobile
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-22 · NCT06977581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Clearview Cancer Institute, Huntsville
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT06119581Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Alabama, Birmingham
Renkami dalyviai2 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-04 · NCT07059091A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 106, Birmingham
Renkami dalyviai3 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-08-11 · NCT07555483Deep Functional Phenotyping of the ALA Lung Health Cohort
- University of Alabama, Birmingham
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 25 iki 35 · Visoms lytims · Atnaujinta 2026-07-17 · NCT06177717Housing, Environment, And Living Conditions for Transformed Health
- UAB Lung Health Center, Birmingham
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 89 · Visoms lytims · Atnaujinta 2026-07-06 · NCT06925373Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- University of Alabama at Birmingham, Birmingham
- University of South Alabama, Mobile
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-30 · NCT05297734Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- University of Alabama at Birmingham, Birmingham
Renkami dalyviai2 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2025-11-12 · NCT05975983Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.